Synthesis, Spectroscopic, and Anticancerous Properties 
                        of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2<sup>′</sup>-Bipyridyl

<table>Structure of [Ag(bpy)(Hdahmp)<sub>2</sub>]NO<sub>3</sub>.</table>

Metal-Based Drugs

sch3

Scheme 3

Scheme 3: Synthesis, Spectroscopic, and Anticancerous Properties 
                        of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2<sup>′</sup>-Bipyridyl 

Scheme 3 | Synthesis, Spectroscopic, and Anticancerous Properties 
                        of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2′-Bipyridyl 

Metal-Based Drugs

Synthesis, Spectroscopic, and Anticancerous Properties of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2′-Bipyridyl

Scheme 3

Synthesis, Spectroscopic, and Anticancerous Properties of Mixed Ligand Palladium(II) and Silver(I) Complexes with 4,6-Diamino-5-hydroxy-2-mercaptopyrimidine and 2,2^′-Bipyridyl